NEW VIEWS ON REJECTION MECHANISMS AND THEIR RELEVANCE TO INTERLEUKIN-2 AS A TREATMENT FOR RENAL-CELL CANCER

被引：12

作者：

OLIVER, RTD

机构：

来源：

EUROPEAN JOURNAL OF CANCER | 1991年 / 27卷 / 09期

关键词：

D O I：

10.1016/0277-5379(91)90318-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1168 / 1172

页数：5

共 65 条

[61] MOLECULAR ANALYSIS OF THE INTERLEUKIN-2 SYSTEM [J].

TANIGUCHI, T ;

MATSUI, H ;

FUJITA, T ;

HATAKEYAMA, M ;

KASHIMA, N ;

FUSE, A ;

HAMURO, J ;

NISHITAKAOKA, C ;

YAMADA, G .

IMMUNOLOGICAL REVIEWS, 1986, 92 :121-133

[62] IMMUNOTHERAPY OF PATIENTS WITH ADVANCED CANCER USING TUMOR-INFILTRATING LYMPHOCYTES AND RECOMBINANT INTERLEUKIN-2 - A PILOT-STUDY [J].

TOPALIAN, SL ;

SOLOMON, D ;

AVIS, FP ;

CHANG, AE ;

FREERKSEN, DL ;

LINEHAN, WM ;

LOTZE, MT ;

ROBERTSON, CN ;

SEIPP, CA ;

SIMON, P ;

SIMPSON, CG ;

ROSENBERG, SA .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) :839-853

[63] T-CELL-DERIVED HELPER FACTOR ALLOWS INVIVO INDUCTION OF CYTO-TOXIC T-CELLS IN NU-NU MICE [J].

WAGNER, H ;

HARDT, C ;

HEEG, K ;

ROLLINGHOFF, M ;

PFIZENMAIER, K .

NATURE, 1980, 284 (5753) :278-280

[64]

Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X

[65]

1991, PRODUCT MONOGRAPH, P48

← 1 2 3 4 5 6 7 →